Global Foot Drop Treatment Market Size (2024 - 2029)

The foot drop treatment market is anticipated to experience significant growth, driven by an increasing demand for treatments related to musculoskeletal disorders, which are a major cause of disability worldwide. The COVID-19 pandemic has further propelled this market, as consumers sought alternative health solutions due to delayed elective surgeries. Despite the potential for new treatment innovations to boost the market, the high cost of certain medical devices may pose a challenge to market expansion.

Market Size of Global Foot Drop Treatment Industry

foot drop treatment market size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 9.50 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Global Foot Drop Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Foot Drop Treatment Market Analysis

The Foot Drop Treatment Market is expected to register a CAGR of 9.5% during the forecast period, 2022-2027.

COVID-19 has uplifted the market studied in a way that ensures a long-term reliance of consumers on bone and joint health supplements. As hospitals are overwhelmed by COVID-19 patients, elective surgeries were canceled or indefinitely delayed. This, in turn, has led consumers toward immediate alternatives such as medications or supplements to ensure proper health, increasing the demand for associated industries, including bone and joint health ingredients. According to the National Osteoporosis Foundation (NOF) survey, osteoporosis patients continued appointments with doctors through various modes in COVID-19: 33% used telephone consultations, 21% used video consultations, 26% used face-to-face appointments, 18% used urgent 'in-person visits, and 3% used other modalities such as instant messaging or attendance for parenteral therapies. As a result, during major lockdowns, the market for foot drop treatment remained mostly unaffected.

A musculoskeletal disorder leads to restricted mobility and it is one of the major contributors worldwide to disability. Musculoskeletal disorder is one of the major causes of foot drop. According to the World Health Organization (WHO), facts published in July 2022, approximately 1.71 billion people have musculoskeletal conditions worldwide. Also, musculoskeletal conditions are the leading contributor to disability worldwide. As per the same source, high-income countries are the most affected in terms of several people - 441 million - followed by countries in the WHO Western Pacific Region with 427 million and the South-East Asia Region with 369 million. Musculoskeletal conditions are also the biggest contributor to years lived with disability (YLDs) worldwide with approximately 149 million YLDs, accounting for 17% of all YLDs worldwide. Thus the increase in musculoskeletal disorders worldwide requires the treatment of these disorders. Thus, the market is expected to see a surge over the forecast period.

Moreover, Heliyon published a study in 2020 in which a pedi-anklebot robot was evaluated for foot drop treatment. Ankle motor performance was measured, and great accuracy in ankle trajectories was observed. Hence, the new emerging treatment options are expected to drive the global foot drop treatment market in the forecast period.

However, the high cost of functional electrical stimulators is likely to impede the market growth over the forecast period.

Foot Drop Treatment Industry Segmentation

Foot drop refers to improper gait functionality that results in difficulty in lifting the front part of the foot. The market is segmented By Product Type (Electrical Stimulator, Braces/Splints), By Application (Neuropathy, Muscle Disorders, and Brain & Spinal Disorders), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type
Functional Electrical Stimulator
Braces/Splints
By Application
Neuropathy
Muscle Disorders
Brain & Spinal Disorders
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Foot Drop Treatment Market Size Summary

The foot drop treatment market is poised for significant growth, driven by an increasing prevalence of musculoskeletal disorders and neurological conditions such as stroke and spinal cord injuries. The demand for effective treatment options is further bolstered by the rising awareness and reliance on bone and joint health supplements, a trend accelerated by the COVID-19 pandemic. The market is characterized by a diverse range of treatment modalities, including functional electrical stimulators, which are gaining traction due to their ability to improve mobility and prevent muscular atrophy. Innovations in treatment technologies, such as the development of the pedi-anklebot robot and the Cionic Neural Sleeve, are expected to enhance therapeutic outcomes and expand market reach.

North America is anticipated to dominate the global foot drop treatment market, attributed to the high incidence of stroke and spinal disorders, alongside a robust pipeline of product approvals. The region's market growth is supported by a competitive landscape featuring key players like Ottobock, Bioness Inc., and Ossur, who are actively engaging in product launches and strategic collaborations. Despite the high cost of some treatment options posing a challenge, the overall market is expected to experience a surge, driven by the increasing demand for advanced and effective foot drop treatment solutions.

Explore More

Global Foot Drop Treatment Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Burden of Chronic Diseases

      2. 1.2.2 Advancements in Products

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Functional Electrical Stimulators

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 Functional Electrical Stimulator

      2. 2.1.2 Braces/Splints

    2. 2.2 By Application

      1. 2.2.1 Neuropathy

      2. 2.2.2 Muscle Disorders

      3. 2.2.3 Brain & Spinal Disorders

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Foot Drop Treatment Market Size FAQs

The Global Foot Drop Treatment Market is projected to register a CAGR of 9.5% during the forecast period (2024-2029)

Bioness Inc. , Saebo Inc. , Boston Orthotics & Prosthetics , Ottobock and Ossur are the major companies operating in the Global Foot Drop Treatment Market.

Foot Drop Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)